Education
About Us
Working with TipRanks
Follow Us
Kilitch Drugs (India) Limited (IN:KILITCH)
:KILITCH
KILITCH Stock Chart & Stats
₹390.55
₹0.95(0.27%)
At close: 4:00 PM EST
₹390.55
₹0.95(0.27%)
Day’s Range― - ―
52-Week Range₹265.50 - ₹490.00
Previous CloseN/A
Volume65.63K
Average Volume (3M)2.19K
Market Cap
₹6.56B
Enterprise Value₹5.31B
Total Cash (Recent Filing)₹593.65M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)22.0
Beta0.99
Next Earnings
Nov 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 20, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)1.84
Shares Outstanding17,480,782
10 Day Avg. Volume2,304
30 Day Avg. Volume2,185
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)2.86
Price to Sales (P/S)2.92
P/FCF Ratio-19.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Kilitch Drugs (India) Limited News
KILITCH FAQ
What was Kilitch Drugs (India) Limited’s price range in the past 12 months?
Kilitch Drugs (India) Limited lowest stock price was ₹265.50 and its highest was ₹490.00 in the past 12 months.
What is Kilitch Drugs (India) Limited’s market cap?
Kilitch Drugs (India) Limited’s market cap is ₹6.56B.
When is Kilitch Drugs (India) Limited’s upcoming earnings report date?
Kilitch Drugs (India) Limited’s upcoming earnings report date is Nov 12, 2025 which is in 10 days.
How were Kilitch Drugs (India) Limited’s earnings last quarter?
Kilitch Drugs (India) Limited released its earnings results on Aug 13, 2025. The company reported ₹1.841 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.841.
Is Kilitch Drugs (India) Limited overvalued?
According to Wall Street analysts Kilitch Drugs (India) Limited’s price is currently Overvalued.
Does Kilitch Drugs (India) Limited pay dividends?
Kilitch Drugs (India) Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Kilitch Drugs (India) Limited dividends here
What is Kilitch Drugs (India) Limited’s EPS estimate?
Kilitch Drugs (India) Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kilitch Drugs (India) Limited have?
Kilitch Drugs (India) Limited has 17,480,782 shares outstanding.
What happened to Kilitch Drugs (India) Limited’s price movement after its last earnings report?
Kilitch Drugs (India) Limited reported an EPS of ₹1.841 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2%.
Which hedge fund is a major shareholder of Kilitch Drugs (India) Limited?
Currently, no hedge funds are holding shares in IN:KILITCH
Company Description
Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited (KILITCH) is a prominent pharmaceutical company based in India, specializing in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company operates in various sectors, including generic and branded formulations, and focuses on therapeutic areas such as anti-infectives, anti-inflammatory drugs, and cardiovascular medications. Kilitch is committed to quality and compliance, ensuring that its products meet stringent regulatory standards, which allows it to serve both domestic and international markets effectively.
Technical Analysis
Ind-Swift Laboratories Ltd.
―
Medicamen Biotech Limited
―
Nectar Lifesciences Ltd.
―
Sakar Healthcare Ltd
―
Venus Remedies Limited
―